MedPath

Adherence Measurement in stable renal transplant patients following conversion form Prograft to advagraf - Admirad

Conditions
Renal transplant patients
MedDRA version: 9.1Level: LLTClassification code 10044439Term: Transplant rejection
Registration Number
EUCTR2008-003231-20-BE
Lead Sponsor
KULeuven
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Adult patients
transplanted min 6m and max 6years at inclusion time
prograft based stable immunosuppressive regimen for at least 3 months
patients able to understand purpose and manipulation of Pro Mate electronic monitoring device
first or second renal transplantation
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

patient with known clinical need at inclusion of withdrawing prograft from regimen within a period of 9 months after inclusion
patients not able to understand manipulation of ProMate electronic monitoring device
patients refusing signature of informed consent
interruption of prograft /advagraf regimen for more then 10 consecutive days
medical reasons rendering the patient not suitable for inclusion

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath